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Abstract 
 
Aim; To identify whether silver is an effective treatment for infected chronic wounds and 
to identify any adverse effects. 
Background; Conflicting evidence exists around the effectiveness and adverse effects of 
silver products which has led to considerable confusion regarding this treatment in 
practice. With some previous systematic reviews and RCTs identifying that not enough 
evidence exists to recommend the use of silver products. However, a systematic review 
conducted by Lo et al (2008) identified that silver was an effective product for wound 
healing and reduction of infection levels, therefore it was important to identify if any 
RCTs had been published from this date to add weight to these conclusions.  
Methods; A systematic review of the literature was conducted using two search 
strategies in order to capture both effectiveness data (RCTs), and adverse effect data 
(RCTs & observational studies). For effectiveness searched; databases were searched 
from 2008- January 2014 using Cochrane CENTRAL, MEDLINE and EMBASE- including 
only randomised controlled trials. Adverse effects data was extracted from from the 
effectiveness results, with the additional searches performed to capture observational 
studies. This search was conducted from 1950- January 2014 using MEDLINE, EMBASE 
and CINAHL databases. 
Results; In total 5 RCTs and 4 observational studies were identified for inclusion in the 
review. It was identified that silver products are an effective treatment for infected 
chronic wounds, based on statistically significant results regarding wound healing and 
infection levels in the included controlled studies- and in combination with the results 
from the systematic review conducted by Lo et al (2008). Additionally, no serious 
adverse effects were identified.  
Conclusion; This systematic review strengthens the case for the use of silver products 
on managing locally infected chronic wounds. However, the use of silver must be 
accompanied E\DWKRURXJKZRXQGDVVHVVPHQWD³WZRZHHNFKDOOHQJH´LVUHFRPPHQGHG
before reassessing for alternative treatment options.  
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Appendix 1 
Table 1, Comparison of systematic reviews 
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Appendix 2 
Effectiveness Search Strategies 
Medline using OVID format using Cochrane Highly Sensitive Search Strategies for 
identifying randomized trials in MEDLINE. 2 search strategies; sensitivity-maximizing 
version and a sensitivity- and precision-maximizing version (Higgins and Green, 2008) 
(It is recommended that searches for trials for inclusion in Cochrane reviews begin with 
the sensitivity-maximizing version in combination with a highly sensitive subject search. 
If this retrieves an unmanageable number of references the sensitivity- and precision-
maximizing version should be used instead)  
Medline search strategy, OVID format, sensitivity- maximising version (2008)  
#1 randomized controlled trial.pt. 
#2 controlled clinical trial.pt. 
#3 randomized.ab. 
#4 placebo.ab. 
#5 drug therapy.fs. 
#6 randomly.ab. 
#7 trial.ab. 
#8 groups.ab. 
#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8  
#10 exp animals/ not humans.sh. 
#11 #9 not #10 
#12 silver.mp. or silver compounds/ or silver nitrate/ or silver sulfadiazine/ 
#13 infection.mp. or wound infection/ 
#14 chronic.mp. or chronic disease/ 
#15 wound.mp. or wound healing/ or skin ulcer/ 
#16 #11 and #12 and # 13 and #14 and #15 
#17 limit #16 to yr= 2008- 2014 
XXI 
 
Medline search strategy, OVID format, sensitivity- and precision-maximizing 
version (2008) 
#1 randomized controlled trial.pt. 
#2 controlled clinical trial.pt. 
#3 randomized.ab. 
#4 placebo.ab. 
#5 clinical trials as topic.sh. 
#6 randomly.ab. 
#7 trial.ti 
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7 
#9 exp animals/ not humans.sh. 
#10 #8 not #9 
#11 silver.mp. or silver compounds/ or silver nitrate/ or silver sulfadiazine/ 
#12 infection.mp. or wound infection/ 
#13 chronic.mp. or chronic disease/ 
#14 wound.mp. or wound healing/ or skin ulcer/ 
#15 #10 and #11 and # 12 and #13 and #14 
#16 limit #15 to yr= 2008- 2014 
EMBASE search strategy, OVID format filter from Wong et al, 2006 
#1 random:.tw. 
#2 placebo:.mp. 
#3 double-blind:.tw. 
#4 #1 or #2 or #3 
#5 silver.mp. or silver chloride/ or silver derivative/ or silver dressing/ or silver 
impregnation/ or silver nanoparticle/ or silver nitrate/ or sulfadiazine silver/ 
#6 exp infection/ or infection.mp. or wound infection/ 
#7 chronic.mp. or chronic wound/ 
#8 exp wound/ or wound.mp. or wound care/ or wound complication/ or wound healing/ 
#9 #5 and #6 and #7 and #8 
XXII 
 
#10 #4 and #9 
#11 limit #10 to yr= 2008- 2014 
CENTRAL- Cochrane Central Register of Controlled trials 
#1 chronic 
#2 silver  
#3 wound 
#4 infection 
#5 #1 and #2 and #3 and #4  
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Appendix 3 
Adverse effects search strategies  
Medline using OVID format (1946 to jan wk 3 2014) searches on 29/01/2014 
>5&7ILOWHUXVHGWRH[FOXGH5&7¶V@  
MEDLINE OVID format, sensitivity- maximising version (2008) 
#1 randomized controlled trial.pt. 
#2 controlled clinical trial.pt. 
#3 randomized.ab.  
#4 placebo.ab. 
#5 drug therapy.fs. 
#6 randomly.ab. 
#7 trial.ab. 
#8 group.ab. 
#9 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 
#10 exp animals/ not humans.sh. 
#11 9 not 10 
#12 silver.mp. or silver compounds/ or silver nitrate/ or silver sulfadiazine/ 
#13 infection.mp. or wound infection/ 
#14 chronic.mp. or chronic disease/ 
#15 wound.mp. or wound healing/ or skin ulcer/ 
#16 (#12 and #13 and#14 and #15) not 11 
Medline search strategy, OVID format, sensitivity- and precision-maximizing 
version (2008) 
#1 randomized controlled trial.pt. 
#2 controlled clinical trial.pt. 
#3 randomized.ab. 
#4 placebo.ab. 
#5 clinical trials as topic.sh. 
XXIV 
 
#6 randomly.ab. 
#7 trial.ti. 
#8 #1 or #2 or #3 or #4 or #5 or #6 or #7 
#9 exp animals/ not humans.sh. 
#10 #8 not #9 
#11 silver.mp. or silver compounds/ or silver nitrate/ or silver sulfadiazine/ 
#12 infection.mp. or wound infection/ 
#13 chronic.mp. or chronic disease/ 
#14 wound.mp. or wound healing/ or skin ulcer/ 
#15 (#11 and #12 and #13 and #14) not #10 
#16 review.ab. 
#17 #15 not #16 
EMBASE search strategy, OVID format filter from Wong et al, 2006- used to 
H[FOXGH5&7¶V 
#1 random:.tw. 
#2 placebo:.mp. 
#3 double-blind:.tw. 
#4 #1 or #2 or #3 
#5 silver.mp. or silver chloride/ or silver derivative/ or silver dressing/ or silver 
impregnation/ or silver nanoparticle/ or silver nitrate/ or sulfadiazine silver/ 
#6 exp infection/ or infection.mp. or wound infection/ 
#7 chronic.mp. or chronic wound/ 
#8 exp wound/ or wound.mp. or wound care/ or wound complication/ or wound healing/ 
#9 #5 and #6 and #7 and #8 
#10 #9 not #4 
#11 review.ab. 
#12 #10 not #11 
CINAHL 
XXV 
 
S1 (MH "Leg Ulcer") OR (MH "Venous Ulcer") OR (MH "Pressure Ulcer") OR (MH "Foot 
8OFHU25ZRXQG´ 
S2 (MH "Silver") OR (MH "Ionic Silver Dressings") OR (MH "Silver Compounds") OR (MH 
"Silver Nitrate") OR (MH "Silver Sulfadiazine") OR "silver"  
60+³,QIHFWLRQ´RU0+³ZRXQGLQIHFWLRQ´RU0+³FKURQLFZRXQG´25³LQIHFWLRQ´
60+³&DVH&RQWURO6WXGLHV´250+³&DVH6WXGLHV´250+³0DWFKHG&DVH
&RQWURO´250+³2QH-6KRW&DVH6WXG\´250+³&DVH0DQDJHPHQW´ 
S5 ((MH "Infection") or (MH "wound infection") or (MH "chronic wound") OR "infection") 
AND (S1 AND S2 AND S3 AND S4)  
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Appendix 4 
Data Extraction Form, Outcomes 1&2 (Adapted from Cochrane Wounds group, 
data extraction form) 
Date of Extraction  
 
Authors   
 
Bibliographic details 
of study 
 
Country of study  
No. of participants 
at start of study 
 
Notes/ short 
description 
 
 
Study eligibility 
 
Study 
characteristics 
Eligibility criteria 
 
Eligibility criteria 
met? 
Yes       No       
Unclear 
Location in text or 
source 
Date of study 2008 onwards   
Type of study Randomised 
Controlled Trial 
  
Participants Adults with an 
infected or heavily 
colonised chronic 
wounds 
  
Type of 
intervention 
Use of silver 
products 
  
Type of 
comparison 
Compared to 
control/ standard 
treatment 
  
Type of outcome 
measures 
-A measure of healing 
rate/ reduction of 
infection i.e. time to 
complete wound healing, 
changes in wound area, 
resolution of 
infection/exudate/ 
inflammation 
-Adverse effects 
  
 
INCLUDE                                                                             EXCLUDE 
Reason for exclusion 
 
 
Do not proceed if study is excluded from the review 
 
 
 
 
 
XXVII 
 
Trial Characteristics 
 
 Description as stated in report/ paper 
Aim of study (e.g. efficacy, 
equivalence etc.) 
 
 
 
 
Study Design 
 
 
Method of Randomisation 
 
 
 
 
 
 
 
 
 
Start date  
End date  
Duration of participation 
(from recruitment to follow-
up) 
 
Ethical approval needed/ 
obtained for the study 
Yes        No      Unclear 
 
 
 
Participants/ population 
 
 Description (include comparative information for each 
intervention or comparison group if available) 
Population description 
(from which study 
participants are drawn) 
 
 
 
 
 
 
Setting (including location 
and social context) 
 
 
 
Inclusion/ Exclusion 
criteria 
 
 
Method of recruitment of 
participants 
(phone, mail, clinic 
patients) 
 
Informed consent 
obtained 
 
Yes        No      Unclear 
 
XXVIII 
 
Baseline imbalances  
 
 
 
Withdrawals and 
exclusions, with reasons 
 
 
 
 
 
 
Patient Characteristics; 
i.e. 
Age 
Sex 
Race/ Ethnicity 
Severity of illness 
Co-morbidities 
Socio-demographic factors 
 
Wound Characteristics; 
i.e. 
Type of wound 
Recurrent wound? 
Duration of wound 
Wound area 
 
 
 
 
 
Study Intervention details 
 
 Description as stated in report/ paper 
Groups involved in 
intervention 
 
No. randomised to 
groups 
 
 
 
Theoretical basis (include 
key references) 
 
 
 
 
Silver product used  
Controls/ comparison 
treatment 
 
Treatment protocol 
 
 
Care setting 
 
 
Care providers 
 
 
XXIX 
 
Co-interventions 
 
 
Duration of intervention 
 
 
Economic information 
 
 
 
Analysis 
 
 Description as stated in report/ paper 
What population analysis 
was performed at 
baseline? 
 
 
 
 
What wound analysis 
was performed at 
baseline? 
 
What infection analysis 
was performed? 
 
 
 
 
 
 
 
 
 
 
XXX 
 
OUTCOME 1- Outcomes in study extracted related to the effectiveness of silver  
 
 Description as stated in report/ paper 
Definition of outcome(s) 
 
 
 
 
 
 
 
 
 
Timing of assessment (s) 
 
 
 
 
Person measuring/ 
reporting outcome 
 
Assumed risk estimate 
(e.g. baseline population 
risk noted in background) 
 
 
 
 
Length of follow-up 
 
 
 
 
Statistics used to assess 
outcome 
 
 
 
 
 
 
 
 
 
Results of outcome(s) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XXXI 
 
OUTCOME 2- Adverse Effects- (information to be extracted as suggested by The Centre 
of Reviews and Dissemination, 2009) 
 Description as stated in report/ paper 
Report of side-effects of 
treatment in paper? 
 
Side-effects of treatment  
 
Frequency, severity and 
seriousness of the 
event(s) 
 
 
Method of monitoring of 
adverse effects (e.g. 
reported at follow-up/ 
patient diary) 
 
Withdrawals from 
treatment due to adverse 
effects 
 
 
 
 
Quality assessment for outcome 2- (Questions from Loke, Price and Herxheimer, 2008)  
On conduct: 
x Are definitions of reported adverse effects given? 
 
x Were the methods used for reporting adverse effects reported?  
 
On reporting: 
x Were any patients excluded from the adverse effects analysis? 
 
x Does the report provide numerical data by intervention group? 
 
x Which categories of adverse effects were reported by the investigators? 
 
$XWKRU¶VFRQFOXVLRQV 
 Description as stated in report/ paper 
Limitations of 
study 
 
 
 
 
 
 
 
 
 
Implication of 
study 
 
 
 
 
 
 
 
 
 
 
XXXII 
 
References to 
other relevant 
studies 
 
 
Comments on the Quality of the RCT (use CASP assessment framework) 
 
 
 
 
 
([WUDFWRU¶VFRPPHQWVRQWKHIROORZLQJ 
-Internal validity 
x Selection bias 
 
 
 
x Performance bias 
 
 
 
 
x Measurement bias 
 
 
 
 
x Attrition bias/ exclusion bias 
 
 
 
 
 
-External validity (Generalizability)- 
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Appendix 5 
Table 2- Characteristics of RCTs included in the review 
 
XXXIV 
 
Appendix 6 
Characteristics of observational studies included in the review 
 
XXXV 
 
Appendix 7 
 
Study 
authors 
and date 
No. of 
partici-
pants 
Trial 
duration 
(weeks) 
 
Type of silver 
product 
 
Wound 
type 
 
Results related to this 
outcome 
Beele et al 
(2010) 
36 4 Silver alginate/ 
carboxymethyl-
cellulose dressing 
PU, VLU -Greater improvement in wound 
healing in test treatment 
-Greater reduction in levels of wound 
infection in test treatment. 
Lazareth 
et al 
(2008) 
102 8 Urgotul ®silver (silver 
lipidocolloid) 
VLU -Greater improvement in wound 
healing in test treatment 
-Greater reduction in levels of wound 
infection in test treatment at week 
4. 
Meaume 
et al 
(2005) 
99 4 Silver releasing 
hydro-alginate  
VLU, PU -mASEPSIS score did not differ 
significantly between groups in first 
2 wks of treatment 
-4 wk closure rate was statistically 
significant in silver test group 
(p=0.024) 
Munter et 
al (2006) 
619 4 Silver-releasing  foam Ulcers of 
varying 
ateologies 
-Statistically significant (p<0.05) 
difference in wound area reduction 
in favour of silver test group. 
-Decreased odour, reduced 
exudates, improved pain 
Verdú et al 
(2004) 
125 6 Charcoal silver 
dressing 
PU with 
wound 
infection 
-Test group had a statistically 
significant (p=0.003) positive effect 
on bacterial management when 
compared to control. 
-Study authors state healing time 
was reduced for test group. 
Woo et al 
(2010) 
34 4 Silver alginate powder 
(arglaes powder) 
A range of 
chronic leg 
and foot 
ulcers 
-Greater rate of wound healing in 
silver test treatment group 
-Greater reduction of infection levels 
in the silver test treatment group 
Randomised studies without clear controls 
Harding et 
al (2012) 
281 8 Aquacel ®Ag vs 
Urgotul ®silver 
VLU -Both dressings were effective at 
promoting healing and reducing 
infection levels. 
Miller et al 
(2010) 
281 12 Nanocrystaline 
(Acticoat, acticoat 
absorbant, acticoat 7) 
Leg ulcer -Greater healing rate in first two 
weeks of treatment than the iodine 
treatment. 
-More effective in wounds that were 
older, larger and had more exudate 
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Appendix 8 
Study 
authors 
and date 
 
Country of 
Study 
 
Patient characteristics 
 
Wound characteristics 
 
Care setting 
Beele et 
al (2010) 
Netherland
s and 
Belgium 
-pop predominantly women 
-mean age 73.4 silver, 73.5 
control group 
-BMI; 30.5 and 27.1 in silver 
and control 
-Diabetes; 33.3% silver, 22.2% 
control 
-Hypertension; 33.3% silver, 
27.5% control 
PU & VLU 
-History of leg ulcer; 50% 
silver, 33.3% control 
-History of PU; 11.1% 
silver, 22.2% control 
 
Not stated, 
however does 
state the patient 
ZDV³YLVLWHG
ZHHNO\´WKHUHIRUH
may be in 
community 
setting. 
Lazareth 
et al 
(2008) 
France -pop predominantly women 
-mean age; 74 
-mean BMI; 28.9kg/m² 
-18.6% were diabetics 
-32.4% had history of  venous 
thrombosis 
 
VLU 
-79.4% were viewed as 
stagnated by the 
investigators 
-leg ulcers were present for 
11 months on average and 
were recurrent 
-71% of patients 
were outpatients, 
recruited from 
hospital 
dermatology and 
vascular 
medicine. 
Woo et 
al (2010) 
Canada -Study sample predominantly 
male 
-Mean age; 55.29 silver, and 
56.9 in control group 
A range of chronic wounds 
present for over a month. 
-most ulcers located below 
the ankle 
Wound care clinic  
Harding 
et al 
(2012) 
UK, 
Germany, 
France, 
Denmark 
and Poland 
-pop predominantly women in 
both treatment groups  
-Mean age; 68.72 in Aquacel 
®Ag group and 71.21 in Urgotul 
®silver group. 
VLU, ABPI= 0.8 or greater, 
duration less than 12 
months, 5-40cm² 
-majority of ulcers were 
classified as deteriorating 
or had shown no progress 
in wound healing 
Participants home 
or in clinic 
Miller et 
al (2010) 
Australia -58.6% of participants were 
female 
-Mean age; 79.67 
Leg ulcers, ABPI= 0.6 or 
above 
-Majority of wounds were 
diagnosed as being venous 
in origin 
-Most wounds were located 
on the lower leg 
Community 
district nursing 
patients, care 
provided in 
SDWLHQWV¶KRPHV
or in clinic 
 
